drugset / Trial / NCT01098747

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

NCT01098747

Phase 3 Completed 335 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare the pain relieving effect of a single-dose of a novel ibuprofen formulation to placebo and two formulations of standard ibuprofen in the treatment of post-surgical dental pain following "wisdom" tooth (third molar) removal.

Timeline

Start
2010-04
Primary completion
2010-07
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg
Subject Ibuprofen Small molecule 512 mg

Indications

No indication recorded.